+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Livestock Medicine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The livestock medicine market is transforming rapidly, driven by heightened regulatory oversight, the emergence of advanced technologies in animal health, and shifting global consumption patterns. Industry leaders are adjusting strategies to keep pace with evolving compliance standards and consumer preferences, ensuring solutions remain relevant in a complex and dynamic environment.

Market Snapshot: Livestock Medicine Market Size and Growth

The livestock medicine market grew from USD 19.77 billion in 2024 to USD 20.82 billion in 2025. It is expected to continue growing at a CAGR of 5.52%, reaching USD 27.30 billion by 2030. This expansion reflects the increasing role of pharmaceutical innovation, digital health solutions, and sustainable animal welfare practices across major agricultural sectors and regions.

Scope & Segmentation of the Livestock Medicine Market

  • Product Types: Anti-inflammatory agents, a comprehensive range of antibiotics (cephalosporins, penicillins, tetracyclines), antiparasitic agents, feed additives (prebiotics, probiotics), hormonal treatments, and vaccines (inactivated, live attenuated, subunit technologies).
  • Disease Categories: Coverage includes infectious diseases, metabolic and nutritional deficiencies, parasitic conditions, and reproductive disorders.
  • Animal Types: Tailored solutions address the needs of aquaculture, cattle, goats, poultry, sheep, and swine operations.
  • Formulations: Products are offered as capsules, gels, liquids, powders, and tablets to match user and administration preferences.
  • Routes of Administration: Includes inhalation, injectable (intramuscular, intravenous), oral (liquid, tablet), and topical (creams, patches) delivery pathways.
  • End Users: Main end users are livestock farmers, veterinary clinics, and veterinary hospitals who require differentiated therapies and diagnostic tools.
  • Regions: The analysis covers Americas (United States—including California, Texas, and other major states—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and beyond).
  • Key Companies: Profiles span market leaders and innovators such as Anicon Labor GmbH by SAN Group GmbH, AniCura Group by Mars Petcare, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Calier Laboratories S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., HESTER BIOSCIENCES LIMITED, HIPRA S.A., Indian Immunologicals Ltd., Koninklijke DSM N.V., Merck KGaA, Neogen Corporation, Norbrook Laboratories Ltd., Parnell Pharmaceuticals Holdings Ltd., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc.

Key Takeaways for Senior Decision-Makers

  • Strategically integrating new digital health platforms and sensor-based monitoring can enhance early disease detection and individualized treatment regimens.
  • Collaboration among animal health professionals, feed manufacturers, and pharmaceutical companies is producing integrated solutions that address complex welfare and sustainability mandates across the value chain.
  • Regulatory shifts, such as stricter antimicrobial usage policies, are accelerating the transition toward advanced therapies, including novel biologics and precision feed solutions.
  • Regional adaptation is essential; market entry and growth strategies must align with localized production trends, government incentives, and changing consumer attitudes, particularly in rapidly developing Asia-Pacific economies.
  • Supply chain alliances and the application of advanced logistics—including blockchain for traceability—are improving the transparent and secure distribution of temperature-sensitive animal health products.

Impacts of United States Tariff Measures on the Livestock Medicine Market

Recent U.S. tariff increases on pharmaceuticals and critical manufacturing components have disrupted traditional global supply chains, compelling industry players to explore localized sourcing and invest in regional production partnerships. These adjustments aim to mitigate rising input costs and supply bottlenecks, while fostering resilience across the animal health value chain.

Methodology & Data Sources

The analysis draws on a robust multi-phase methodology: peer-reviewed secondary research, over fifty primary stakeholder interviews, and proprietary data sets on therapeutic practices and production volumes. Triangulation and scenario modeling were used to validate trends and quantitative insights, all peer-reviewed by a panel of industry experts before publication.

Why This Report Matters for Strategic Decision-Making

  • Provides a comprehensive roadmap for prioritizing R&D, supply chain configuration, and commercial initiatives in response to evolving regulatory and technological landscapes.
  • Delivers actionable intelligence on regional market dynamics, enabling competitive positioning and local partnership development.
  • Equips senior executives to anticipate operational risks and capitalize on next-generation therapy opportunities in the livestock medicine market.

Conclusion

Staying agile in the livestock medicine market requires evidence-based planning across innovation, compliance, and supply resilience. This report clarifies critical drivers and equips decision-makers to realize growth and operational efficiency in an evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of novel antimicrobial peptides to combat resistant bacterial infections in dairy cattle
5.2. Integration of precision livestock monitoring sensors for real-time disease diagnostics and medication dosing
5.3. Development of plant-based immunostimulants reducing antibiotic dependency in swine production
5.4. Regulatory shifts incentivizing vaccine deployment and enhanced biosafety measures in poultry farming
5.5. Expansion of long-acting injectable anthelmintic formulations to improve compliance in sheep herds
5.6. Growth of telemedicine platforms enabling remote veterinary consultations and prescription management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Livestock Medicine Market, by Product Type
8.1. Introduction
8.2. Anti-inflammatory Agents
8.3. Antibiotics
8.3.1. Cephalosporins
8.3.2. Penicillins
8.3.3. Tetracyclines
8.4. Antiparasitic Agents
8.4.1. Ectoparasiticides
8.4.2. Endoparasiticides
8.5. Feed Additives
8.5.1. Prebiotics
8.5.2. Probiotics
8.6. Hormones
8.6.1. Growth Hormones
8.6.2. Reproductive Hormones
8.7. Vaccines
8.7.1. Inactivated Vaccines
8.7.2. Live Attenuated Vaccines
8.7.3. Subunit Vaccines
9. Livestock Medicine Market, by Disease Type
9.1. Introduction
9.2. Infectious Diseases
9.3. Metabolic Diseases
9.4. Nutritional Deficiency Diseases
9.5. Parasitic Diseases
9.6. Reproductive Diseases
10. Livestock Medicine Market, by Animal Type
10.1. Introduction
10.2. Aquaculture
10.3. Cattle
10.4. Goats
10.5. Poultry
10.6. Sheep
10.7. Swine
11. Livestock Medicine Market, by Formulation
11.1. Introduction
11.2. Capsules
11.3. Gels
11.4. Liquids
11.5. Powders
11.6. Tablets
12. Livestock Medicine Market, by Route of Administration
12.1. Introduction
12.2. Inhalation
12.3. Injectable
12.3.1. Intramuscular
12.3.2. Intravenous
12.4. Oral
12.4.1. Liquids
12.4.2. Tablets
12.5. Topical
12.5.1. Creams
12.5.2. Patches
13. Livestock Medicine Market, by End Users
13.1. Introduction
13.2. Livestock Farmers
13.3. Veterinary Clinics
13.4. Veterinary Hospitals
14. Americas Livestock Medicine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Livestock Medicine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Livestock Medicine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Anicon Labor GmbH by SAN Group GmbH
17.3.2. AniCura Group by Mars Petcare
17.3.3. Biogenesis Bago SA
17.3.4. Boehringer Ingelheim International GmbH
17.3.5. Calier Laboratories S.A.
17.3.6. Ceva Sante Animale
17.3.7. Dechra Pharmaceuticals PLC
17.3.8. Elanco Animal Health Inc.
17.3.9. HESTER BIOSCIENCES LIMITED
17.3.10. HIPRA S.A.
17.3.11. Indian Immunologicals Ltd.
17.3.12. Koninklijke DSM N.V.
17.3.13. Merck KGaA
17.3.14. Neogen Corporation
17.3.15. Norbrook Laboratories Ltd.
17.3.16. Parnell Pharmaceuticals Holdings Ltd.
17.3.17. Phibro Animal Health Corporation
17.3.18. Vetoquinol S.A.
17.3.19. Vetpharma Animal Health S.L.
17.3.20. Virbac SA
17.3.21. Zoetis Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LIVESTOCK MEDICINE MARKET: RESEARCHAI
FIGURE 28. LIVESTOCK MEDICINE MARKET: RESEARCHSTATISTICS
FIGURE 29. LIVESTOCK MEDICINE MARKET: RESEARCHCONTACTS
FIGURE 30. LIVESTOCK MEDICINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY NUTRITIONAL DEFICIENCY DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY NUTRITIONAL DEFICIENCY DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GOATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SHEEP, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SHEEP, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 191. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 194. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 195. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 196. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 197. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 198. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 199. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 200. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 201. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 202. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 203. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 204. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 205. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 212. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 213. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 214. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 215. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 216. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 217. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 218. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 236. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 237. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 242. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 243. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 244. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 245. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 336. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 338. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 339. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
TABLE 340. UNITED KINGDOM LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM LIVESTOCK

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Livestock Medicine market report include:
  • Anicon Labor GmbH by SAN Group GmbH
  • AniCura Group by Mars Petcare
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Calier Laboratories S.A.
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • HESTER BIOSCIENCES LIMITED
  • HIPRA S.A.
  • Indian Immunologicals Ltd.
  • Koninklijke DSM N.V.
  • Merck KGaA
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Parnell Pharmaceuticals Holdings Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Vetpharma Animal Health S.L.
  • Virbac SA
  • Zoetis Inc.

Table Information